Qin, L., Zhang, J., Xiao, Y., Liu, K., Cui, Y., Xu, F., Ren, W., Yuan, Y., Jiang, C., Ning, S., Ye, X., Zeng, M., Qian, H., Bian, A., Li, F., Yang, G., Tang, S., Zhang, Z., Dai, J., Guo, J., Wang, Q., Sun, B., Ge, Y., Ouyang, C., Xu, X., Wang, J., Huang, Y., Cui, H., Zhou, J., Wang, M., Su, Z., Lu, Y., Wu, D., Shi, J., Liu, W., Dong, L., Pan, Y., Zhao, B., Cui, Y., Gao, X., Gao, Z., Ma, X., Chen, A., Wang, J., Cao, M., Cui, Q., Chen, L., Chen, F., Yu, Y., Ji, Q., Zhang, Z., Gu, M., Zhuang, X., Lv, X., Wang, H., Pan, Y., Wang, L., Xu, X., Zhao, J., Wang, X., Liu, C., Liang, N., Xing, C., Liu, J., & Wang, N. (2022). a novel long-term intravenous combined with local treatment with human amnion-derived mesenchymal stem cells for a multidisciplinary rescued uremic calciphylaxis patient and the underlying mechanism. Journal of molecular cell biology, 14, . http://access.bl.uk/ark:/81055/vdc_100157999714.0x000025